Related Experiment Video
Updated: Jul 13, 2026

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
Current state of screening for bladder cancer
Ralph Madeb1, Dragan Golijanin, Joy Knopf
1University of Rochester School of Medicine, Department of Urology, Rochester, NY, USA.
Abstract:
Bladder cancer is the fourth most commonly diagnosed cancer in men and the eighth most common cancer in women in the USA. Efforts to reduce mortality from bladder cancer must focus on three areas: prevention, development of effective therapies for muscle-invasive and metastatic disease, and early detection of potentially invasive lesions while they are still superficial and amenable to less morbid, but still effective, treatments. As more effective therapies for metastatic transitional cell carcinoma are not on the immediate horizon and preventive measures (except for smoking cessation) have been disappointing, if we are to reduce this disease's morbidity and mortality rates significantly, early detection strategies need to be improved and implemented. The goal of screening for any type of cancer is to detect the disease in its early stages in order to increase the chances for cure or prolongation of life (before micro or gross metastases occur). Since all patients who die of bladder cancer do so from metastases and since almost all patients with metastases have muscle-invading cancers appearing as the first bladder cancer event, diagnosing cancers destined to become muscle invading before they actually are should reduce bladder cancer mortality. This special report reviews the current state of bladder cancer screening in the USA.
Insights
Improving early detection of bladder cancer is crucial for reducing mortality. Current screening strategies need enhancement to identify invasive lesions before they spread, improving patient outcomes.
Area of Science:
- Oncology
- Urology
- Public Health
Background:
- Bladder cancer is a significant health concern, ranking as the 4th most common cancer in men and 8th in women in the USA.
- Reducing bladder cancer mortality requires advancements in prevention, treatment for advanced stages, and early detection.
- Current preventive measures, excluding smoking cessation, have shown limited success, and effective therapies for metastatic disease are not immediately available.
Purpose of the Study:
- To review the current status of bladder cancer screening in the USA.
- To emphasize the importance of early detection for improving bladder cancer survival rates.
- To highlight the need for improved early detection strategies to reduce disease morbidity and mortality.
Main Methods:
- Review of current bladder cancer screening practices in the USA.
- Analysis of the role of early detection in cancer management.
- Discussion of the link between early diagnosis and improved patient prognosis.
Main Results:
- Early detection of bladder cancer is critical for successful treatment, especially for preventing metastasis.
- Diagnosing cancers before they become muscle-invasive can significantly reduce bladder cancer mortality.
- Current screening methods require improvement and wider implementation to effectively detect early-stage bladder cancer.
Conclusions:
- Enhanced early detection strategies are essential for significantly reducing bladder cancer morbidity and mortality.
- Screening aims to detect cancer early, increasing chances for cure and prolonged survival.
- Focusing on detecting bladder cancers before they become muscle-invasive is key to lowering mortality rates.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Imaging Studies III: Computed Tomography
Imaging Studies II: Ultrasonography
Urologic Endoscopic Procedure: Cystoscopic Examination
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies I: Kidney, Ureter, and Bladder Studies
